VWF and thrombotic thrombocytopenic purpura: Representative gel analyses of patients with COVID-19 having increased VWF concentrations and antibodies to ADAMTS13, critically ill patients without COVID-19 and, for reasons of comparison, patients with acute TTP are presented in Fig. 2 and Supplementary Fig. 1.